X-149546949-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000393985.8(EOLA1):c.464G>A(p.Gly155Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000899 in 1,201,760 control chromosomes in the GnomAD database, including 1 homozygotes. There are 32 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000393985.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EOLA1 | NM_001171907.3 | c.464G>A | p.Gly155Glu | missense_variant | 5/5 | ENST00000393985.8 | NP_001165378.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EOLA1 | ENST00000393985.8 | c.464G>A | p.Gly155Glu | missense_variant | 5/5 | 1 | NM_001171907.3 | ENSP00000421745 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000405 AC: 44AN: 108731Hom.: 0 Cov.: 19 AF XY: 0.000386 AC XY: 12AN XY: 31069
GnomAD3 exomes AF: 0.000108 AC: 13AN: 120426Hom.: 0 AF XY: 0.0000546 AC XY: 2AN XY: 36638
GnomAD4 exome AF: 0.0000586 AC: 64AN: 1092980Hom.: 1 Cov.: 30 AF XY: 0.0000557 AC XY: 20AN XY: 358846
GnomAD4 genome AF: 0.000404 AC: 44AN: 108780Hom.: 0 Cov.: 19 AF XY: 0.000385 AC XY: 12AN XY: 31130
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 09, 2021 | The c.464G>A (p.G155E) alteration is located in exon 5 (coding exon 2) of the CXorf40A gene. This alteration results from a G to A substitution at nucleotide position 464, causing the glycine (G) at amino acid position 155 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at